FDA Grants Avastin Safety Hearing For Genentech
The U.S. Food and Drug Administration on Thursday granted Genentech Inc. a hearing to defend its popular drug Avastin as a safe, effective treatment for metastatic breast cancer, after the agency...To view the full article, register now.
Already a subscriber? Click here to view full article